Drug Trial Radar · NCT06971731
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Oct 20, 2025
Primary completion
Mar 1, 2028
Study completion Apr 1, 2028
Sponsor
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.Otsuka
- Sponsor type
- Industry
- First posted
- May 14, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 4 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 3 study will evaluate the safety, effectiveness, tolerability, and how the body processes JNT-517 in children, adolescents, and adults with phenylketonuria. Participants will be randomly assigned to receive either JNT-517 or placebo during an initial 6-week treatment period. After this period, eligible participants will receive JNT-517 for an additional 46 weeks.
Conditions
- Phenylketonuria
Interventions
JNT-517Drug
JNT-517 orally
JNT-517 Matching PlaceboDrug
JNT-517 matching placebo orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute Change in Plasma Phenylalanine (Phe) From Baseline to the Mean of Weeks 2, 4, and 6 in the JNT-517 High Dose BID Dose Group at End of Period 1Time frame: Baseline to End of Period 1 (Week 6)
Locations
26 sites in 10 countries. Site status is shown where the registry gives one.
University of California Los Angeles (UCLA) School of Medicine
Los Angeles, California · Recruiting
University of Florida (UF) Health Shands Hospital
Gainesville, Florida · Recruiting
University of South Florida
Tampa, Florida · Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois · Recruiting
Oregon Health and Science University
Portland, Oregon · Recruiting
University of Pittsburgh Medical Center (UPMC) - Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania · Recruiting
Vanderbilt University Medical Center
Nashville, Tennessee · Recruiting
University of Texas Southwestern
Dallas, Texas · Recruiting
University of Texas Health (UTHealth) Science Center at Houston
Houston, Texas · Recruiting
Utah Health - The University of Utah Hospital
Salt Lake City, Utah · Recruiting
Royal Adelaide Hospital
Adelaide, Australia · Recruiting
Royal Melbourne Hospital
Parkville, Australia · Recruiting
Mater Health - Mater Hospital Brisbane
South Brisbane, Australia · Recruiting
M.A.G.I.C Clinic
Calgary, Alberta, Canada · Recruiting
Fakultní nemocnice Královské Vinohrady
Prague, Czechia · Recruiting
Centre Hospitalier Régional Universitaire (CHRU) de Tours - Hôpital Bretonneau
Tours, France · Recruiting
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz
Mainz, Germany · Recruiting
Universitätsklinikum Münster
Münster, Germany · Recruiting
Nihon University Hospital
Chiyoda-ku, Japan · Recruiting
Osaka Metropolitan University Hospital
Osaka, Japan · Recruiting
Fujita Health University
Toyoake, Japan · Recruiting
Universitair Medisch Centra (AMC)- Amsterdam
Amsterdam, Netherlands · Recruiting
Beatrix Children's Hospital
Groningen, Netherlands · Recruiting
Pomorski Uniwersytet Medyczny w Szczecinie
Szczecin, Poland · Recruiting
Hospital Universitario Ramón y Cajal
Madrid, Spain · Recruiting
Hospital Clinico Universitario de Santiago de Compostela
Santiago de Compostela, Spain · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.